UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From GOLD 0 to Pre-COPD

American journal of respiratory and critical care medicine, 2021-02, Vol.203 (4), p.414-423

2021

Volltextzugriff (PDF)

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

The New England journal of medicine, 2018-05, Vol.378 (18), p.1671-1680

2018

Volltextzugriff (PDF)

Effect of a single exacerbation on decline in lung function in COPD

Respiratory medicine, 2017-07, Vol.128, p.85-91

2017

Volltextzugriff (PDF)

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

Respiratory research, 2020-07, Vol.21 (1), p.177-10, Article 177

2020

Volltextzugriff (PDF)

The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial

American journal of respiratory and critical care medicine, 2020-11, Vol.202 (9), p.1237-1243

2020

Volltextzugriff (PDF)

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial

Respiratory research, 2018-10, Vol.19 (1), p.196-11, Article 196

2018

Volltextzugriff (PDF)

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort

The lancet respiratory medicine, 2014-04, Vol.2 (4), p.267-276

2014

Volltextzugriff (PDF)

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

Respiratory research, 2020-06, Vol.21 (1), p.139-12, Article 139

2020

Volltextzugriff (PDF)

Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation

American journal of respiratory and critical care medicine, 2019-05, Vol.199 (10), p.1195-1204

2019

Volltextzugriff (PDF)

Exacerbation frequency and course of COPD

International journal of chronic obstructive pulmonary disease, 2012-01, Vol.7 (default), p.653-661

2012

Volltextzugriff (PDF)

InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations

Respiratory research, 2021-04, Vol.22 (1), p.130-14, Article 130

2021

Volltextzugriff (PDF)

Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers: An interpretative phenomenological analysis

Palliative medicine, 2004-10, Vol.18 (7), p.619-625

2004

Volltextzugriff (PDF)

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial

Lung, 2011-08, Vol.189 (4), p.261-268

2011

Volltextzugriff (PDF)

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2020-06, Vol.201 (12), p.1508-1516

2020

Volltextzugriff (PDF)

Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study

BMJ open respiratory research, 2024-05, Vol.11 (1), p.e001890

2024

Volltextzugriff (PDF)

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

The lancet respiratory medicine, 2019-09, Vol.7 (9), p.745-756

2019

Volltextzugriff (PDF)

A randomised controlled trial of the effect of automated interactive calling combined with a health risk forecast on frequency and severity of exacerbations of COPD assessed clinically and using EXACT PRO

Primary care respiratory journal, 2011-09, Vol.20 (3), p.324-331

2011

Volltextzugriff (PDF)

The effect of exacerbation history on outcomes in the IMPACT trial

The European respiratory journal, 2020-05, Vol.55 (5), p.1901921

2020

Volltextzugriff (PDF)

Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases

American journal of respiratory and critical care medicine, 2024-08, Vol.210 (3), p.281-287

2024

Volltextzugriff (PDF)

Identifying COPD patients at increased risk of mortality: Predictive value of clinical study baseline data

Respiratory medicine, 2008-11, Vol.102 (11), p.1615-1624

2008

Volltextzugriff (PDF)

Evaluating the effectiveness of combination therapy to prevent COPD exacerbations: the value of NNT analysis

International journal of clinical practice (Esher), 2005-10, Vol.59 (10), p.1187-1194

Halpin, D. M. G.

2005

Volltextzugriff (PDF)

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

Advances in therapy, 2020-09, Vol.37 (9), p.3775-3790

2020

Volltextzugriff (PDF)

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.2681-2695

2019

Volltextzugriff (PDF)

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10, p.239-259

2015

Volltextzugriff (PDF)

Preference for different relaxation techniques by COPD patients: comparison between six techniques

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.2315-2319

2016

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(99)

Sprache

Englisch
(99)

Erscheinungsjahr

n.n

Thema

Humans
(99)
Female
(91)
Male
(91)
Life Sciences & Biomedicine
(90)
Science & Technology
(90)
Middle Aged
(87)
Adult
(48)
Aged, 80 And Over
(36)
Respiratory System
(30)
Treatment Outcome
(24)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Risk Factors
(23)
Chronic Obstructive Pulmonary Disease
(20)
General & Internal Medicine
(20)
Retrospective Studies
(20)
Patients
(19)
Pulmonary Disease, Chronic Obstructive - Drug Therapy
(19)
Adolescent
(16)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

From GOLD 0 to Pre-COPD

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

Effect of a single exacerbation on decline in lung function in COPD

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation

Exacerbation frequency and course of COPD

InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations

Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers: An interpretative phenomenological analysis

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

A randomised controlled trial of the effect of automated interactive calling combined with a health risk forecast on frequency and severity of exacerbations of COPD assessed clinically and using EXACT PRO

The effect of exacerbation history on outcomes in the IMPACT trial

Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases

Identifying COPD patients at increased risk of mortality: Predictive value of clinical study baseline data

Evaluating the effectiveness of combination therapy to prevent COPD exacerbations: the value of NNT analysis

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis

Preference for different relaxation techniques by COPD patients: comparison between six techniques

Aktive Filter

Suchergebnisse filtern